A Phase II Open Label Study of SU101 for Patients With Anaplastic Astrocytoma in First Relapse
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2012
At a glance
- Drugs Leflunomide (Primary)
- Indications Anaplastic astrocytoma
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.